Status:
COMPLETED
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Conditions:
Advanced Idiopathic Parkinson's Disease
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to collect health economic data depicting the initial levels and natural progression over time of resource usage, Parkinson's disease (PD)-related costs, and hea...
Eligibility Criteria
Inclusion
- \- Advanced idiopathic Parkinson's disease
Exclusion
- \- Other diseases which might influence compliance or participation in the study
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT00141518
Start Date
March 1 2006
End Date
April 1 2011
Last Update
July 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.